<b>Venetoclax Plus Azacitidine Versus 7+3 Induction in Adults Aged 18–64 Years With Newly Diagnosed Acute Myeloid Leukemia: A Single-Center Retrospective Cohort Study</b>

Huahua Wei

Open source

DOI
10.6084/m9.figshare.33368998.v1
Published
2026
Container
Not recorded
Publisher
figshare
Open access
yes

Credibility signals

limited evidence Score 47/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.6084/m9.figshare.33368998.v1,
  title = {<b>Venetoclax Plus Azacitidine Versus 7+3 Induction in Adults Aged 18–64 Years With Newly Diagnosed Acute Myeloid Leukemia: A Single-Center Retrospective Cohort Study</b>},
  author = {Huahua Wei},
  year = {2026},
  doi = {10.6084/m9.figshare.33368998.v1},
  url = {https://doi.org/10.6084/m9.figshare.33368998.v1}
}

RIS

TY  - JOUR
TI  - <b>Venetoclax Plus Azacitidine Versus 7+3 Induction in Adults Aged 18–64 Years With Newly Diagnosed Acute Myeloid Leukemia: A Single-Center Retrospective Cohort Study</b>
AU  - Huahua Wei
PY  - 2026
DO  - 10.6084/m9.figshare.33368998.v1
UR  - https://doi.org/10.6084/m9.figshare.33368998.v1
ER  - 

APA

Wei, H. (2026). <b>Venetoclax Plus Azacitidine Versus 7+3 Induction in Adults Aged 18–64 Years With Newly Diagnosed Acute Myeloid Leukemia: A Single-Center Retrospective Cohort Study</b>. https://doi.org/10.6084/m9.figshare.33368998.v1

Source records